Get started
Author

Carlos Carrascoso-Rubio

Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2020 · Helena Montanuy, Águeda Martínez-Barriocanal, et al. · Clinical Cancer Research · 34
Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1
2021 · Carlos Carrascoso-Rubio, Hidde A. Zittersteijn, et al. · Stem Cell Research & Therapy · 6
PDF
Premature ageing of lung alveoli and bone marrow cells from Terc deficient mice with different telomere lengths
2025 · Rosa Guerrero-López, Cristina Manguán-García, et al. · Scientific Reports · 1
PDF
Data from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 6 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 7 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Figure 4 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Data from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 2 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Figure 8 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Figure 3 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 5 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 1 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Text from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 4 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Figure 7 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 3 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Figure 5 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Figure 8 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 2 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Text from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Supplementary Figure 6 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
PDF
Supplementary Figure 1 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
2023 · Helena Montanuy, Águeda Martínez-Barriocanal, et al.
Works count: 27
Citation count: 41
H-index: 2
I10-index: 1
Year
Topic
Type